Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

2012 New England Journal of Medicine 7,563 citations

Abstract

Intratumor heterogeneity can lead to underestimation of the tumor genomics landscape portrayed from single tumor-biopsy samples and may present major challenges to personalized-medicine and biomarker development. Intratumor heterogeneity, associated with heterogeneous protein function, may foster tumor adaptation and therapeutic failure through Darwinian selection. (Funded by the Medical Research Council and others.).

Keywords

Computational biologyEvolutionary biologyBiology

MeSH Terms

BiomarkersTumorBiopsyCarcinomaRenal CellChromosome AberrationsEverolimusEvolutionMolecularExomeGenetic HeterogeneityHumansImmunosuppressive AgentsKidneyKidney NeoplasmsMutationNeoplasm MetastasisPhenotypePhylogenyPloidiesPolymorphismSingle NucleotideSequence AnalysisDNASirolimus

Affiliated Institutions

Related Publications

Hallmarks of Cancer: New Dimensions

Abstract The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity of cancer phenotypes and genotypes into a provisional set of underlying...

2022 Cancer Discovery 7899 citations

Publication Info

Year
2012
Type
article
Volume
366
Issue
10
Pages
883-892
Citations
7563
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

7563
OpenAlex
155
Influential
6585
CrossRef

Cite This

Marco Gerlinger, Andrew J. Rowan, Stuart Horswell et al. (2012). Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing. New England Journal of Medicine , 366 (10) , 883-892. https://doi.org/10.1056/nejmoa1113205

Identifiers

DOI
10.1056/nejmoa1113205
PMID
22397650
PMCID
PMC4878653

Data Quality

Data completeness: 86%